Morgan Stanley’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$845 Hold
1,139
﹤0.01% 7456
2025
Q4
$1.54K Hold
1,139
﹤0.01% 7292
2025
Q3
$1.38K Hold
1,139
﹤0.01% 7361
2025
Q2
$1.02K Buy
1,139
+1,130
+12,556% +$1.48K ﹤0.01% 7334
2025
Q1
$16 Hold
9
﹤0.01% 7992
2024
Q4
$26 Hold
9
﹤0.01% 7811
2024
Q3
$32 Hold
9
﹤0.01% 7724
2024
Q2
$44 Hold
9
﹤0.01% 7541
2024
Q1
$69 Sell
9
-10
-53% -$62 ﹤0.01% 7421
2023
Q4
$156 Buy
19
+10
+111% +$63 ﹤0.01% 7381
2023
Q3
$77 Hold
9
﹤0.01% 7463
2023
Q2
$104 Hold
9
﹤0.01% 7492
2023
Q1
$634 Hold
9
﹤0.01% 7408
2022
Q4
$738 Sell
9
-1
-10% -$101 ﹤0.01% 7516
2022
Q3
$1K Sell
10
-3
-23% -$431 ﹤0.01% 7617
2022
Q2
$2K Sell
13
-15
-54% -$3.55K ﹤0.01% 7612
2022
Q1
$11K Sell
28
-3
-10% -$1.01K ﹤0.01% 7386
2021
Q4
$12K Sell
31
-77
-71% -$44.8K ﹤0.01% 7419
2021
Q3
$80K Sell
108
-84
-44% -$70.3K ﹤0.01% 6491
2021
Q2
$201K Sell
192
-183
-49% -$219K ﹤0.01% 6014
2021
Q1
$559K Buy
375
+362
+2,785% +$526K ﹤0.01% 5094
2020
Q4
$14K Sell
13
-42
-76% -$38.2K ﹤0.01% 6551
2020
Q3
$40K Buy
55
+20
+57% +$19.1K ﹤0.01% 5804
2020
Q2
$24K Buy
35
+20
+133% +$8.97K ﹤0.01% 5966
2020
Q1
$5K Sell
15
-41
-73% -$16.2K ﹤0.01% 6230
2019
Q4
$45K Buy
56
+35
+167% +$42K ﹤0.01% 5890
2019
Q3
$29K Buy
21
+10
+91% +$16K ﹤0.01% 5904
2019
Q2
$24K Buy
11
+3
+38% +$6.09K ﹤0.01% 5876
2019
Q1
$12K Buy
8
+5
+167% +$7.86K ﹤0.01% 6142
2018
Q4
$3K Buy
+3
New +$4.27K ﹤0.01% 6382
2018
Q3
Sell
-30
Closed -$38K 6822
2018
Q2
$39K Buy
+30
New +$49.3K ﹤0.01% 5979
2018
Q1
Hold
0
6711

Other funds holding YCBD

Morgan Stanley's YCBD Position: Q1 2026 in Review

Morgan Stanley held its cbdMD (YCBD) position steady in Q1 2026 at 1,139 shares worth $845. The position accounts for ﹤0.01% of the portfolio, ranked #7456.

Morgan Stanley first reported a position in YCBD in Q2 2018 and has held it in 31 quarters since. The position peaked at $559K in Q1 2021. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Morgan Stanley held 1,139 shares of cbdMD worth $845 as of Q1 2026.
  • Morgan Stanley left its cbdMD share count unchanged in Q1 2026.
  • cbdMD made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7456 holding.
  • Morgan Stanley first reported a position in cbdMD in Q2 2018 and has held it in 31 quarters since.
  • Morgan Stanley's cbdMD position peaked at $559K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.